Canada markets closed

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.0900+0.1500 (+3.81%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
16,515
16,515
36,439
57,184
27,909
Selling General and Administrative
23,799
23,799
16,383
17,086
6,772
Total Operating Expenses
38,075
38,075
28,918
13,393
-20,557
Operating Income or Loss
-38,075
-38,075
-28,918
-13,393
20,557
Interest Expense
315.284
315.284
301.584
294.459
469.151
Total Other Income/Expenses Net
-4,388
-4,388
10,433
-3,480
3.996
Income Before Tax
-42,194
-42,194
-18,715
-17,145
20,118
Income Tax Expense
0
0
25.629
0
-
Income from Continuing Operations
-42,194
-42,194
-18,741
-17,145
20,118
Net Income
-42,194
-42,194
-18,741
-17,145
20,118
Net Income available to common shareholders
-42,194
-42,194
-18,741
-17,145
20,118
Basic EPS
-5.60
-
-4.31
-6.30
4.63
Diluted EPS
-5.60
-
-4.31
-6.30
4.63
Basic Average Shares
4,956
-
4,352
2,734
4,347
Diluted Average Shares
4,956
-
4,352
2,734
4,347